Cure My Disease

Don't miss your cure!

Log in / Sign up

← Back to home

Astellas Pharma Inc

Clinical trials sponsored by Astellas Pharma Inc, explained in plain language.

Astellas Pharma Inc. 4503 TOKYO

Global pharmaceutical company developing innovative medicines.

Not investment advice. Company information is shown for context only. Clinical trials frequently fail.

Trials to join now! 3 Not yet finished but already full! 2 Completed 9 Terminated 1

New drug targets tough cancers with specific gene flaw

Disease control Terminated

This early-stage study tests a new drug called ASP4396 in adults with advanced solid tumors that have a specific KRAS G12D mutation. The drug is given by IV infusion, and the main goals are to check safety, find the right dose, and see how the body handles it. About 175 participa…

Phase: PHASE1 • Sponsor: Astellas Pharma Inc • Aim: Disease control

Last updated Jul 18, 2026 00:00 UTC